Intraco Chemicals Limited 06604715 false 2023-01-01 2023-12-31 2023-12-31 The principal activity of the company is that of trading with pharmaceutical products outside the United Kingdom Digita Accounts Production Advanced 6.30.9574.0 true false 06604715 2023-01-01 2023-12-31 06604715 2023-12-31 06604715 core:CurrentFinancialInstruments 2023-12-31 06604715 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 06604715 bus:SmallEntities 2023-01-01 2023-12-31 06604715 bus:AuditExemptWithAccountantsReport 2023-01-01 2023-12-31 06604715 bus:FilletedAccounts 2023-01-01 2023-12-31 06604715 bus:SmallCompaniesRegimeForAccounts 2023-01-01 2023-12-31 06604715 bus:RegisteredOffice 2023-01-01 2023-12-31 06604715 bus:Director4 2023-01-01 2023-12-31 06604715 bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 06604715 core:ComputerEquipment 2023-01-01 2023-12-31 06604715 countries:UnitedKingdom 2023-01-01 2023-12-31 06604715 2022-01-01 2022-12-31 06604715 2022-12-31 06604715 core:CurrentFinancialInstruments 2022-12-31 06604715 core:CurrentFinancialInstruments core:WithinOneYear 2022-12-31 06604715 core:CostValuation 2022-12-31 iso4217:GBP xbrli:pure

Registration number: 06604715

Intraco Chemicals Limited

Unaudited Filleted Abridged Financial Statements

for the Year Ended 31 December 2023

 

Intraco Chemicals Limited

Contents

Company Information

1

Abridged Balance Sheet

2 to 3

Notes to the Unaudited Abridged Financial Statements

4 to 6

 

Intraco Chemicals Limited

Company Information

Director

Christoffel Johannes Erasmus

Registered office

5th Floor
86 Jermyn Street
London
SW1Y 6AW

Accountants

Verfides
5th Floor
86 Jermyn Street
London
SW1Y 6AW

 

Intraco Chemicals Limited

(Registration number: 06604715)
Abridged Balance Sheet as at 31 December 2023

Note

2023
CHF

2022
CHF

Fixed assets

 

Investments

4

3,642,631

3,642,631

Current assets

 

Debtors

4,759,744

5,206,900

Cash at bank and in hand

 

20,976

528,444

 

4,780,720

5,735,344

Prepayments and accrued income

 

4,650

14,115

Creditors: Amounts falling due within one year

(24,260,698)

(24,942,114)

Net current liabilities

 

(19,475,328)

(19,192,655)

Total assets less current liabilities

 

(15,832,697)

(15,550,024)

Accruals and deferred income

 

(4,024)

(6,974)

Net liabilities

 

(15,836,721)

(15,556,998)

Capital and reserves

 

Called up share capital

1,527

1,527

Retained earnings

(15,838,248)

(15,558,525)

Shareholders' deficit

 

(15,836,721)

(15,556,998)

For the financial year ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

 

Intraco Chemicals Limited

(Registration number: 06604715)
Abridged Balance Sheet as at 31 December 2023

Approved and authorised by the director on 23 September 2024
 

.........................................

Christoffel Johannes Erasmus

Director

 

Intraco Chemicals Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 December 2023

1

General information

The company is a private company limited by share capital, incorporated in United Kingdom.

The address of its registered office is:
5th Floor
86 Jermyn Street
London
SW1Y 6AW

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements were prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

These financial statements are prepared in Swiss Francs which is the functional currency of the company and are rounded to the nearest whole Franc.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

 

Intraco Chemicals Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 December 2023

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Tangible assets

Reducing balance

Business combinations

Business combinations are accounted for using the purchase method. The consideration for each acquisition is measured at the aggregate of the fair values at acquisition date of assets given, liabilities incurred or assumed, and equity instruments issued by the group in exchange for control of the acquired, plus any costs directly attributable to the business combination. When a business combination agreement provides for an adjustment to the cost of the combination contingent on future events, the group includes the estimated amount of that adjustment in the cost of the combination at the acquisition date if the adjustment is probable and can be measured reliably.

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.


Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

 

Intraco Chemicals Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 December 2023

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Financial instruments

Basic financial instruments are recognised at amortised cost, except for investments in non-convertible preference and non-puttable ordinary shares which are measured at fair value, with changes recognised in profit or loss. Derivative financial instruments are initially recorded at cost and thereafter at fair value with changes recognised in profit or loss.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2022 - 1).

4

Investments

Total
CHF

Cost or valuation

At 1 January 2023

3,642,631

Carrying amount

At 31 December 2023

3,642,631

At 31 December 2022

3,642,631